Calixa Therapeutics
Calixa Therapeutics, a biopharmaceutical company, develops a novel cephalosporin to address the problem of multi-drug resistant organisms.
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | - | ||
N/A | Acquisition | ||
| Total Funding | - | ||
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | - | ||
N/A | Acquisition | ||
| Total Funding | - | ||